CoChat

Activation of the GLP-1 Receptors in the Nucleus of the Solitary Tract Reduces Food Reward Behavior and Targets the Mesolimbic System

Open access

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

The gut/brain peptide, glucagon like peptide 1 (GLP-1), suppresses food intake by acting on receptors located in key energy balance regulating CNS areas, the hypothalamus or the hindbrain. Moreover, GLP-1 can reduce reward derived from food and motivation to obtain food by acting on its mesolimbic receptors. Together these data suggest a neuroanatomical segregation between homeostatic and reward effects of GLP-1. Here we aim to challenge this view and hypothesize that GLP-1 can regulate food reward behavior by acting directly on the hindbrain, the nucleus of the solitary tract (NTS), GLP-1 receptors (GLP-1R). Using two models of food reward, sucrose progressive ratio operant conditioning and conditioned place preference for food in rats, we show that intra-NTS microinjections of GLP-1 or Exendin-4, a stable analogue of GLP-1, inhibit food reward behavior. When the rats were given a choice between palatable food and chow, intra-NTS Exendin-4 treatment preferentially reduced intake of palatable food but not chow. However, chow intake and body weight were reduced by the NTS GLP-1R activation if chow was offered alone. The NTS GLP-1 activation did not alter general locomotor activity and did not induce nausea, measured by PICA. We further show that GLP-1 fibers are in close apposition to the NTS noradrenergic neurons, which were previously shown to provide a monosynaptic connection between the NTS and the mesolimbic system. Central GLP-1R activation also increased NTS expression of dopamine-β-hydroxylase, a key enzyme in noradrenaline synthesis, indicating a biological link between these two systems. Moreover, NTS GLP-1R activation altered the expression of dopamine-related genes in the ventral tegmental area. These data reveal a food reward-suppressing role of the NTS GLP-1R and indicate that the neurobiological targets underlying food reward control are not limited to the mesolimbic system, instead they are distributed throughout the CNS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0119034

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Representative photomicrograph of a coronal section of the rat brain at the level of the NTS illustrating the microinjection site (encircled area) for the behavioral experiments (right panel) and a schematic representation of the NTS from the rat atlas (Paxinos and Watson, 1998) (left panel). Area postrema (AP), central canal (cc), gracile nucleus (Gr).
Fig 1 Representative photomicrograph of a coronal section of the rat brain at the level of the NTS illustrating the microinjection site (encircled area) for the behavioral experiments (right panel) and a schematic representation of the NTS from the rat atlas (Paxinos and Watson, 1998) (left panel). Area postrema (AP), central canal (cc), gracile nucleus (Gr).CC BY · PubMed Central
Fig 2 NTS GLP-1R activation preferentially affects intake of palatable food but not chow. Direct NTS GLP-1R stimulation with Ex4 suppressed the intake of palatable food (peanut butter) but not chow when both were offered simultaneously. The effect of Ex4 had a short latency (noted 1h after injection), and lasted throughout the 6h of measurements. The food intake data are represented as grams eaten (A), as calories consumed, since the two foods differ in their caloric density (B), and as the fraction of total intake (by calories) that was represented by the palatable peanut butter intake(C). Data are expressed as mean ±SEM. n = 12 per each treatment group. * p<0.05, ** p<0.01, *** p<0.005.
Fig 2 NTS GLP-1R activation preferentially affects intake of palatable food but not chow. Direct NTS GLP-1R stimulation with Ex4 suppressed the intake of palatable food (peanut butter) but not chow when both were offered simultaneously. The effect of Ex4 had a short latency (noted 1h after injection), and lasted throughout the 6h of measurements. The food intake data are represented as grams eaten (A), as calories consumed, since the two foods differ in their caloric density (B), and as the fraction of total intake (by calories) that was represented by the palatable peanut butter intake(C). Data are expressed as mean ±SEM. n = 12 per each treatment group. * p<0.05, ** p<0.01, *** p<0.005.CC BY · PubMed Central
Fig 3 GLP-1R stimulation by Ex4 in the NTS reduces chow intake and body weight. Intra-NTS delivery of Ex4 reduced the consumption of chow over the 22h period of data collection (A-B). Body weight (g) was also reduced 22h after injections (C). In a second group of rats intake of kaolin (PICA response) was measured simultaneously with chow intake. While the chow intake was significantly reduced after intra NTS Ex4 administration (D), intake of kaolin was not altered by Ex4 (E). Data are expressed as mean ±SEM. n = 11 per each treatment group (A-C), n = 8 per each treatment group (D-E). * p<0.05, ** p<0.01, ***P < 0.005, **** p<0.0005.
Fig 3 GLP-1R stimulation by Ex4 in the NTS reduces chow intake and body weight. Intra-NTS delivery of Ex4 reduced the consumption of chow over the 22h period of data collection (A-B). Body weight (g) was also reduced 22h after injections (C). In a second group of rats intake of kaolin (PICA response) was measured simultaneously with chow intake. While the chow intake was significantly reduced after intra NTS Ex4 administration (D), intake of kaolin was not altered by Ex4 (E). Data are expressed as mean ±SEM. n = 11 per each treatment group (A-C), n = 8 per each treatment group (D-E). * p<0.05, ** p<0.01, ***P < 0.005, **** p<0.0005.CC BY · PubMed Central
Fig 4 GLP-1R stimulation in the NTS decreased food-motivated behavior. The effect of intra-NTS injection of Ex4 on progressive ratio operant responding for sucrose was tested. Ex4 potently decreased the number of sucrose rewards earned (A) and the number of active lever presses (B) in an operant lever-pressing paradigm. Importantly this suppression in food-motivated behavior was not associated with a reduction in locomotor activity (C). n = 11 per each treatment group. ** p<0.01, ***P < 0.0005.
Fig 4 GLP-1R stimulation in the NTS decreased food-motivated behavior. The effect of intra-NTS injection of Ex4 on progressive ratio operant responding for sucrose was tested. Ex4 potently decreased the number of sucrose rewards earned (A) and the number of active lever presses (B) in an operant lever-pressing paradigm. Importantly this suppression in food-motivated behavior was not associated with a reduction in locomotor activity (C). n = 11 per each treatment group. ** p<0.01, ***P < 0.0005.CC BY · PubMed Central
Fig 5 GLP-1 injected into the NTS decreased food-motivated behavior. GLP-1 decreased the number of sucrose rewards earned (A) and the number of active lever presses (B) in an operant lever-pressing paradigm, and this suppression in food-motivated behavior was not associated with a reduction in locomotor activity (C). n = 11 per each treatment group. * p<0.05.
Fig 5 GLP-1 injected into the NTS decreased food-motivated behavior. GLP-1 decreased the number of sucrose rewards earned (A) and the number of active lever presses (B) in an operant lever-pressing paradigm, and this suppression in food-motivated behavior was not associated with a reduction in locomotor activity (C). n = 11 per each treatment group. * p<0.05.CC BY · PubMed Central
Fig 6 GLP-1R stimulation in the NTS decreased food reward behavior. The effect of intra-NTS injection of Ex4 on the ability of palatable food to condition a place preference was tested. Preference for the chamber paired to palatable food was abolished by Ex4 treatment. The preference [% conditioned place preference (CPP)] was calculated using the following formula: ((test − pre-test)/(total time − pre-test)) × 100. n = 11 (vehicle group) and n = 8 (Ex4 group). ****p < 0.0005. Data represent mean ±SEM.
Fig 6 GLP-1R stimulation in the NTS decreased food reward behavior. The effect of intra-NTS injection of Ex4 on the ability of palatable food to condition a place preference was tested. Preference for the chamber paired to palatable food was abolished by Ex4 treatment. The preference [% conditioned place preference (CPP)] was calculated using the following formula: ((test − pre-test)/(total time − pre-test)) × 100. n = 11 (vehicle group) and n = 8 (Ex4 group). ****p < 0.0005. Data represent mean ±SEM.CC BY · PubMed Central
Fig 7 NTS expression of two enzymes key in noradrenaline synthesis after central GLP-1R stimulation. Central activation of GLP-1R with Ex4 increases the expression of dBH but not TH or CCK. Data are expressed as mean ±SEM. n = 9 (pair-fed control group), n = 11 (ad libitum fed control group) and n = 10 (Ex4 group). *p<0.05. Tyrosine hydroxylase (TH) and dopamine-beta-hydroxylase (dBH).
Fig 7 NTS expression of two enzymes key in noradrenaline synthesis after central GLP-1R stimulation. Central activation of GLP-1R with Ex4 increases the expression of dBH but not TH or CCK. Data are expressed as mean ±SEM. n = 9 (pair-fed control group), n = 11 (ad libitum fed control group) and n = 10 (Ex4 group). *p<0.05. Tyrosine hydroxylase (TH) and dopamine-beta-hydroxylase (dBH).CC BY · PubMed Central
Fig 8 Many YFP-immunoreactive axons (green) closely apposed the TH-positive neurons (red) of the NTS. Fluorescent YFP– preproglucagon neurons (green) and DAPI (nuclear stain, blue) in coronal sections through the NTS of YFP–PPG mice. Micrographs showing the caudal NTS (A-B), the NTS at the level of the area postrema (C-D) and the NTS at the level of the 4th ventricle (E-F). Cell bodies of YFP-immunoreactive preproglucagon neurons (green) were detected at the level of the area postrema and just caudally to the area postrema (A-D). Many green YFP-immunoreactive axons closely appose blue DAPI-labeled cell bodies in the NTS. White arrows indicate NTS TH-positive neuronal cell bodies closely apposed by the GLP-1 fibers. Insets in panels B,D and F show the interaction at a single neuron level. Area postrema (AP), central canal (cc), dorsal motor nucleus of the vagus (DMV), gracile nucleus (Gr), 4th ventricle (4thV). B,D and F show higher magnification of areas in A,C and D, respectively.
Fig 8 Many YFP-immunoreactive axons (green) closely apposed the TH-positive neurons (red) of the NTS. Fluorescent YFP– preproglucagon neurons (green) and DAPI (nuclear stain, blue) in coronal sections through the NTS of YFP–PPG mice. Micrographs showing the caudal NTS (A-B), the NTS at the level of the area postrema (C-D) and the NTS at the level of the 4th ventricle (E-F). Cell bodies of YFP-immunoreactive preproglucagon neurons (green) were detected at the level of the area postrema and just caudally to the area postrema (A-D). Many green YFP-immunoreactive axons closely appose blue DAPI-labeled cell bodies in the NTS. White arrows indicate NTS TH-positive neuronal cell bodies closely apposed by the GLP-1 fibers. Insets in panels B,D and F show the interaction at a single neuron level. Area postrema (AP), central canal (cc), dorsal motor nucleus of the vagus (DMV), gracile nucleus (Gr), 4th ventricle (4thV). B,D and F show higher magnification of areas in A,C and D, respectively.CC BY · PubMed Central
Fig 9 Activation of GLP-1R in the NTS alters gene expression in the mesolimbic reward system. GLP-1R activation by Ex4 in the NTS increased the mRNA expression of the gene that encodes tyrosine hydroxylase (TH), and dopamine 2 receptor (Drd2) without significantly changing the mRNA expression of other dopamine receptors in the VTA (A). The expression of several other genes previously associated with changes in reward behavior: FosB, Creb1 and Gad1 remained unchanged after intra-NTS Ex4 treatment (B). Intra-NTS Ex4 treatment did not alter the expression of dopamine receptors, dopamine transporter (DAT), FosB, Gad1 or Creb1 in the nucleus accumbens (Fig C-D). Data are expressed as mean ±SEM. n = 6 (vehicle group) and n = 5 (Ex4 group). ** p<0.01, *** p<0.005. Dopamine receptor 1 (Drd1a), dopamine receptor 3 (Drd3), dopamine receptor 5 (Drd5), glutamate decarboxylase 1 (Gad1), cAMP responsive element binding protein 1 (Creb1), FBJ osteosarcoma viral oncogene B (FosB).
Fig 9 Activation of GLP-1R in the NTS alters gene expression in the mesolimbic reward system. GLP-1R activation by Ex4 in the NTS increased the mRNA expression of the gene that encodes tyrosine hydroxylase (TH), and dopamine 2 receptor (Drd2) without significantly changing the mRNA expression of other dopamine receptors in the VTA (A). The expression of several other genes previously associated with changes in reward behavior: FosB, Creb1 and Gad1 remained unchanged after intra-NTS Ex4 treatment (B). Intra-NTS Ex4 treatment did not alter the expression of dopamine receptors, dopamine transporter (DAT), FosB, Gad1 or Creb1 in the nucleus accumbens (Fig C-D). Data are expressed as mean ±SEM. n = 6 (vehicle group) and n = 5 (Ex4 group). ** p<0.01, *** p<0.005. Dopamine receptor 1 (Drd1a), dopamine receptor 3 (Drd3), dopamine receptor 5 (Drd5), glutamate decarboxylase 1 (Gad1), cAMP responsive element binding protein 1 (Creb1), FBJ osteosarcoma viral oncogene B (FosB).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Research works printed but not linked: 1

  1. Alhadeff AL, Rupprecht LE, Hayes MR (2011) GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake. Endocrinology. · DOI · Paper page

Cited by

See all 168

Metadata

Authors
Richard, J. E., Anderberg, R. H., Göteson, A., Gribble, F. M., Reimann, F., & Skibicka, K. P.
Affiliations
  • University of Gothenburg (SE)
  • University of Cambridge (GB)
Corresponding author
Skibicka, Karolina P.
Venue
PLOS ONE
Published
2015-03-20
Volume
10
Issue
3
Pages
e0119034
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2070532232
Cited by
168
References
60
Citations by year
2026: 21 · 2025: 14 · 2024: 15 · 2023: 14 · 2022: 11 · 2021: 18 · 2020: 13 · 2019: 13 · 2018: 13 · 2017: 12 · 2016: 14 · 2015: 10
FWCI
9.05
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Wellcome Trust (WT088357Z/09/Z, WT084210Z/07/Z)
  • Novo Nordisk
  • Vetenskapsrådet (2011-03054)
  • Göteborgs Universitet
  • Novo Nordisk Fonden (NNF13OC0003886)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
GLP-1 receptor, nucleus tractus solitarius, food reward, mesolimbic system, exendin-4, noradrenergic neurons, dopamine beta-hydroxylase, ventral tegmental area, palatable food intake, conditioned place preference, hindbrain, energy homeostasis
MeSH terms
Glucagon-Like Peptide-1 Receptor, Animals, Behavior, Animal, Conditioning, Operant, Eating, Female, Food, Male, Motivation, Norepinephrine, Reward, Gene Expression, Solitary Nucleus, Rats, Adrenergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Activation of the GLP-1 Receptors in the Nucleus of the Solitary Tract Reduces Food Reward Behavior and Targets the Mesolimbic System. https://app.cochat.ai/papers/10.1371/journal.pone.0119034
The paper
Richard, J. E., Anderberg, R. H., Göteson, A., Gribble, F. M., Reimann, F., & Skibicka, K. P. (2015). Activation of the GLP-1 Receptors in the Nucleus of the Solitary Tract Reduces Food Reward Behavior and Targets the Mesolimbic System. PLOS ONE. https://doi.org/10.1371/journal.pone.0119034

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.